Elie S. Dolgin

Elie S. Dolgin's AcademicInfluence.com Rankings

Elie S. Dolgin

Communications

#4394

World Rank

#6143

Historical Rank

Journalism

#498

World Rank

#567

Historical Rank

communications Degrees

Download Badge

Communications

Elie S. Dolgin's Degrees

Bachelors Biology University of Pennsylvania
Masters Journalism Columbia University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Elie S. Dolgin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Elie S. Dolgin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The myopia boom (2015) (601)
INBREEDING AND OUTBREEDING DEPRESSION IN CAENORHABDITIS NEMATODES (2007) (176)
Syrian gas attack reinforces need for better anti-sarin drugs (2013) (163)
The tangled history of mRNA vaccines (2021) (144)
In good company (2017) (139)
The Fate of Transposable Elements in Asexual Populations (2006) (123)
The Effects of Recombination Rate on the Distribution and Abundance of Transposable Elements (2008) (112)
Failed Alzheimer’s trial does not kill leading theory of disease (2016) (85)
COVID vaccine immunity is waning — how much does that matter? (2021) (85)
Hakuna Nematoda: genetic and phenotypic diversity in African isolates of Caenorhabditis elegans and C. briggsae (2008) (80)
Cancer reproducibility project releases first results (2017) (78)
Thanks for sharing (2013) (74)
The most popular genes in the human genome (2017) (62)
Long-acting HIV drugs advanced to overcome adherence challenge (2014) (55)
Send in the senolytics (2020) (52)
Population frequencies of transposable elements in selfing and outcrossing Caenorhabditis nematodes. (2008) (50)
The race for antiviral drugs to beat COVID — and the next pandemic (2021) (50)
What lava lamps and vinaigrette can teach us about cell biology (2018) (48)
How COVID unlocked the power of RNA vaccines (2021) (46)
Leading Alzheimer’s theory survives drug failure (2016) (44)
Big pharma moves from 'blockbusters' to 'niche busters' (2010) (40)
CureVac COVID vaccine let-down spotlights mRNA design challenges (2021) (40)
Encapsulate this (2014) (37)
Omicron is supercharging the COVID vaccine booster debate. (2021) (36)
What lava lamps and vinaigrette can teach us about cell biology. (2018) (36)
The most popular genes in the human genome. (2017) (32)
Pan-coronavirus vaccine pipeline takes form (2022) (31)
Bringing down the cost of cancer treatment. (2018) (30)
Oncolytic viruses get a boost with first FDA-approval recommendation (2015) (30)
mRNA flu shots move into trials (2021) (29)
Anticancer autophagy inhibitors attract ‘resurgent’ interest (2019) (29)
Diabetes: Encapsulating the problem (2016) (29)
Omicron thwarts some of the world’s most-used COVID vaccines (2022) (29)
Bringing down the cost of cancer treatment (2018) (27)
How to defeat dementia (2016) (27)
First GPCR-directed antibody passes approval milestone (2018) (26)
Taking tissue engineering to heart (2011) (25)
Rapid antidepressant effects of ketamine ignite drug discovery (2013) (25)
BTK blockers make headway in multiple sclerosis (2021) (25)
Radioactive drugs emerge from the shadows to storm the market (2018) (24)
Is one vaccine dose enough if you’ve had COVID? What the science says (2021) (24)
Mouse library set to be knockout (2011) (23)
The inverse of immunity (2010) (23)
COVID-19 vaccines poised for launch, but impact on pandemic unclear. (2020) (23)
Trial failure prompts soul-searching for critical-care specialists (2012) (22)
Putting stem cells to the test (2010) (22)
Venerable brain-cancer cell line faces identity crisis (2016) (22)
Segregation and the evolution of sex under overdominant selection. (2003) (21)
Lupus in crisis: as failures pile up, clinicians call for new tools (2019) (20)
Spinal muscular atrophy approval boosts antisense drugs (2017) (20)
Animal rule for drug approval creates a jungle of confusion (2013) (20)
Medical devices: Managed by machine (2012) (20)
Targeting hotspots of transmission promises to reduce malaria (2010) (20)
Technology: Dressed to detect (2014) (20)
How secret conversations inside cells are transforming biology (2019) (19)
Fluctuating baseline pain implicated in failure of clinical trials (2010) (18)
African networks launch to boost clinical trial capacity (2010) (18)
Animalgesic effects (2010) (18)
The knockout rat pack (2010) (18)
Flaw in induced-stem-cell model (2011) (18)
Deprivation: A wake-up call (2013) (18)
Will cell-based meat ever be a dinner staple? (2020) (17)
Early clinical data raise the bar for hemophilia gene therapies (2016) (17)
'Game changer' antibiotic and others in works for superbug (2011) (17)
Sizzling interest in lab-grown meat belies lack of basic research (2019) (17)
How to start a lab when funds are tight (2018) (17)
The world at their feet (2018) (17)
The secret social lives of viruses (2019) (17)
Personalized investigation (2010) (17)
The Sticking Point (2013) (16)
Next-generation stem cell therapy poised to enter EU market (2015) (16)
Drug startups coalesce around condensates (2021) (16)
DNA's secret weapon against knots and tangles (2017) (16)
Cancer-eating immune cells kitted out with CARs (2020) (16)
How protein-based COVID vaccines could change the pandemic (2021) (16)
Phylogeny: Rewriting evolution (2012) (16)
Fighting cancer with microbes (2020) (15)
Sequencing of superbugs seen as key to combating their spread (2010) (15)
This is your brain online: the Functional Connectomes Project (2010) (14)
Business: The billion-dollar biotech (2015) (14)
Massive NIH–industry project opens portals to target validation (2019) (13)
Nonprofit disease groups earmark grants for drug repositioning (2011) (13)
Alzheimer’s disease is getting easier to spot (2018) (13)
Using DNA, radiation therapy gets personal. (2016) (13)
Age-related macular degeneration foils drugmakers (2017) (13)
The mathematician versus the malignancy (2014) (13)
The bioengineering of cannabis (2019) (12)
Human genomics: The genome finishers (2009) (12)
Companies race to develop first Hedgehog inhibitor cancer drug (2011) (12)
Publication checklist proposed to boost rigor of pilot trials (2013) (12)
Massive schizophrenia genomics study offers new drug directions (2014) (12)
Hantavirus treatments advance amidst outbreak in US park (2012) (12)
Drug discoverers chart path to tackling data irreproducibility (2014) (12)
Antibody engineers seek optimal drug targeting TIGIT checkpoint (2020) (12)
Antidotes edge closer to reversing effects of new blood thinners (2013) (12)
Cancer's true breakthroughs (2013) (12)
Minipig, minipig, let me in (2010) (11)
Cancer–neuronal crosstalk and the startups working to silence it (2020) (11)
FDA narrows drug label usage (2009) (11)
FDA clearance paves way for computerized ADHD monitoring (2014) (11)
Sound medicine (2012) (11)
The kill-switch for CRISPR that could make gene-editing safer (2020) (11)
tRNA therapeutics burst onto startup scene (2022) (10)
Unlocking the potential of vaccines built on messenger RNA (2019) (10)
Cancer metastasis scrutinized (2009) (10)
Companies hope for kinase inhibitor JAKpot (2011) (10)
Heat shock and awe (2011) (10)
There’s no limit to longevity, says study that revives human lifespan debate (2018) (10)
A history of drugs on the weight list (2012) (10)
Antibody drugs set to revive flagging migraine target (2013) (10)
As E. coli continues to claim lives, new approaches offer hope (2011) (10)
‘Super-antibodies’ could curb COVID-19 and help avert future pandemics (2021) (9)
To serve and neuroprotect (2012) (9)
New technologies aim to take cancer out of circulation (2011) (9)
Epic $12 billion deal and FDA's approval raise CAR-T to new heights (2017) (9)
First GM pigs for allergies. Could xenotransplants be next? (2021) (9)
Bioengineering: Doing without donors (2017) (9)
Research technique: The murine candidate (2011) (8)
New anti-IL-23 drugs raise hopes for psoriasis plaque clearance (2016) (8)
First CD123-targeted drug approved after wowing in rare cancer (2019) (8)
IGF-1R drugs travel from cancer cradle to Graves’ (2020) (8)
Drug pipeline is flush with new options for chronic constipation (2012) (8)
PubMed Commons closes its doors to comments (2018) (8)
Oncolytic viruses get a boost with first FDA-approval recommendation (2015) (8)
Preemptive genotyping trialed to prevent adverse drug reactions (2011) (8)
Drugmakers go nuclear, continuing push into radiopharmaceuticals (2021) (8)
Technology: Barriers to misuse (2015) (7)
GM microbes created that can’t escape the lab (2015) (7)
Scientists downsize bold plan to make human genome from scratch (2018) (7)
Letter campaign sought to pressure FDA action on stem cell clinics (2014) (7)
Animal testing alternatives come alive in US (2010) (7)
Collins sets out his vision for the NIH (2009) (7)
Textiles: Fabrics of life (2015) (7)
Portable pathology for Africa (2015) (7)
Cancer vaccines: Material breach (2013) (7)
Call in the backup (2012) (7)
Embryonic stem cell lines given the go-ahead (2010) (7)
New, intensive trials planned on heels of Mississippi HIV 'cure' (2013) (7)
When it takes two to tango, FDA suggests a new regulatory dance (2011) (6)
Climate change: As the ice melts (2017) (6)
Gene flaw found in induced stem cells (2010) (6)
NIH faces marching orders on orphan drug shortage (2011) (6)
Better lipids to power next generation of mRNA vaccines. (2022) (6)
The young and the restless (2017) (6)
Chronic controversy continues over mysterious XMRV virus (2010) (6)
Survey details stem cell clinics ahead of regulatory approval (2010) (6)
CRISPR hacks enable pinpoint repairs to genome (2017) (6)
Gene therapies advance, but some see manufacturing challenges (2012) (6)
Antidotes progress for new oral clotbusters (2015) (6)
AI face-scanning app spots signs of rare genetic disorders (2019) (6)
Immunology: Oral solutions (2014) (6)
Industry embraces virtual trial platforms (2018) (6)
CAR-Ts move beyond B-cell cancers to myeloma (2017) (6)
News Feature: Gene therapy successes point to better therapies (2019) (6)
From spinach scare to cancer care. (2011) (6)
Therapies: Progressive steps (2016) (5)
Maize genome mapped (2009) (5)
Inner Workings: Genomics blazes a trail to improved cannabis cultivation (2019) (5)
New data protection rules could harm research, science groups say (2014) (5)
Old mice require new experimental tricks to study aging process (2013) (5)
First therapy targeting Parkinson's proteins enters clinical trials (2012) (5)
In Brazil, basic stem cell research lags behind clinical trials (2011) (5)
Trial puts niacin—and cholesterol dogma—in the line of fire (2011) (5)
Oral solutions. (2015) (5)
Cancer immunology community seeks better end points (2016) (5)
T-cell vaccines could top up immunity to COVID, as variants loom large (2021) (5)
Pharmacogenetic tests yield bonus benefit: better drug adherence (2013) (5)
Coronapod: CureVac disappoints in COVID vaccine trial. (2021) (5)
Human-subjects research: The ethics squad (2014) (5)
Devices: Artificial inspiration (2012) (5)
Core Concept: The pandemic is prompting widespread use—and misuse—of real-world data (2020) (5)
Patent-free pact pushes the boundaries of precompetitive research (2014) (5)
First eczema biologic debuts but price could restrict use (2017) (5)
Trial networks move beyond single-disease strategies (2011) (5)
Search for better COVID vaccines confounded by existing rollouts (2021) (4)
Immunotherapy takes aim at exhausted T cells (2020) (4)
The shape-shifting blobs that shook up cell biology (2022) (4)
Oncogene-specific advocacy groups bring a patient-centric perspective to studies of lung cancer (2020) (4)
Anti-inflammatory drug cuts risk of heart disease — and cancer (2017) (4)
Colour blindness corrected by gene therapy (2009) (4)
Anti-IL-5 biologics carve out severe-asthma niche (2014) (4)
Diabetes cell therapies take evasive action (2022) (4)
What legal weed in Canada means for science (2018) (4)
First soluble TCR therapy opens ‘new universe’ of cancer targets (2022) (4)
A cellular puzzle: The weird and wonderful architecture of RNA (2015) (4)
‘Bubble boy’ gene therapy reignites commercial interest (2019) (4)
The Ultimate Endpoint (2012) (4)
Treg engineers take aim at autoimmunity (2021) (4)
Synthetic biology: Safety boost for GM organisms. (2015) (4)
THE ELABORATE ARCHITECTURE OF RNA (2015) (3)
CD47 checkpoint data supercharge Stanford spinout IPO (2018) (3)
‘Psychological fear’: MIT scientists of Chinese origin protest toxic US climate (2019) (3)
Four-strain flu vaccines coming to a pharmacy near you (2012) (3)
Mutation-specific cystic fibrosis treatments on verge of approval (2011) (3)
Anti-CD3 drug keeps diabetes at bay (2019) (3)
Better standards sought for range of stem cells entering the clinic (2014) (3)
Lp(a)-lowering drugs bolster cardiovascular pipeline (2020) (3)
Real Males Eat Yogurt (2012) (3)
Verve takes base editors into humans (2022) (3)
Could computer models be the key to better COVID vaccines? (2022) (3)
Jewish genetic screening grows despite questions about breadth (2011) (3)
Specter of eye toxicity looms over BCMA-targeted therapy (2020) (3)
Panel backs pain drug studies with new safety checks (2012) (3)
Time to ditch stand-alone stem cell oversight panels, experts say (2013) (3)
In vision trial, some researchers would rather see double (2010) (3)
BMS bets on targeting IL-8 to enhance cancer immunotherapies (2016) (3)
The hunt for the lesser-known funding source (2019) (3)
Stem cells: The impatient advocate (2010) (3)
Trial designs for vaccines adapt to the times (2012) (3)
Straight talk with...George Daley (2010) (3)
Genomic focus brings tea research to the boil (2019) (3)
Publication bias continues despite clinical-trial registration (2009) (3)
Genomics uncovers microbe resistance (2010) (3)
Human mutation rate revealed (2009) (3)
Core Concept: Chimeras keep courting controversy (2016) (3)
Loxo TRK inhibitor data wows oncologists (2017) (3)
Sequencing reveals suite of commensal and pathogenic viruses (2011) (3)
Inner Workings: Combating antibiotic resistance from the ground up (2016) (3)
As leukemia options grow, drugs jockey to be first-line therapies (2013) (2)
Inner Workings: Taking evolution to the clinic (2015) (2)
The brain's traffic problems. (2019) (2)
Vaccine protects against HIV virus (2009) (2)
Orphan cystic fibrosis drugs find sister diseases (2011) (2)
The resistant rice of the future (2009) (2)
Amid legal uncertainties, NIH approves more embryonic stem cells (2011) (2)
You know you want to... (2017) (2)
Lack of uptake threatens promise of HIV vaccines (2010) (2)
New targets for old drugs (2009) (2)
First 'breakthrough' drugs designated, but dilution worries linger (2013) (2)
Gender tokenism and bias prevail in biotech boardrooms (2017) (2)
How going green can raise cash for your lab (2018) (2)
To halt brain diseases, drugs take aim at protein traffic jams that kill neurons (2019) (2)
Responding to the call of home (2019) (2)
Underestimate of HIV reservoirs threatens purging approach (2013) (2)
Outside the lab: Side jobs for scientists (2017) (2)
Drug companies look to biomarkers to salvage cancer target (2012) (2)
Trial success spurs planning for rollout of HIV prevention pills (2011) (2)
Pig kidney transplant obscures value of engineered animals. (2021) (2)
Longer exclusivity sought for fixed-dose drug combinations (2013) (2)
Slime for a Dime (2007) (2)
NIH research grants yield economic windfall (2017) (2)
The sounds of science: biochemistry and the cosmos inspire new music (2019) (2)
Indian ancestry revealed (2009) (2)
A drug to block fat intake and combat cancer spread. (2021) (2)
Patents draw new lines in the battle to commercialize stem cells (2010) (2)
p53 prevents pluripotency (2009) (2)
Better forecasting urged to avoid drug waste (2010) (2)
NIH accused of being overly literal on stem cell approvals (2012) (2)
Quarter-dose of Moderna COVID vaccine still rouses a big immune response. (2021) (2)
Synthetic biology speeds vaccine development (2020) (2)
Straight talk with...Stephen O'Brien (2013) (2)
Clinical efficacy data on gene tests trails marketing in psychiatry (2012) (2)
Straight talk with... Robert Beall (2012) (1)
New genetic engineering tools for human embryonic stem cells (2007) (1)
Cancer immunotherapy advances spawn calls for new endpoints (2013) (1)
Big biology projects warm up to preprints (2016) (1)
Talkin' 'bout my (third) generation (2010) (1)
An act of tolerance (2012) (1)
Getting a fix on SMA (2012) (1)
Genetics: The hexanucleotide hex (2017) (1)
The murine candidate (2011) (1)
Smart sewers for public health (2015) (1)
Inner Workings: Malnutrition, gutted (2015) (1)
Applying A. S. Makarenko's Experience to The Practical Work of The School (1970) (1)
Startups set off new wave of mRNA therapeutics (2021) (1)
COVID’s cardiac connection (2021) (1)
When Huntington’s disease comes early (2018) (1)
In Haiti, collapsed AIDS clinics fret over new challenges (2010) (1)
Gap in stem cell funding could drive Australian brain drain. (2010) (1)
Blood feud erupts over Roche's bispecific antibody for hemophilia (2017) (1)
Behind the paper: Stepping up to the antiplatelet (2011) (1)
Genzyme, though unique, could be a bellwether for US biotech (2011) (1)
Setbacks rattle allergy vaccine frontrunners, but hopes remain (2016) (1)
Mental health: Monsters in the mirror (2015) (1)
This is how a pathologist could save your life (2018) (1)
Could tracking RNA in body fluids reveal disease? (2020) (1)
Massive biobank yields first results—with more to come (2011) (1)
Unconventional γδ T cells ‘the new black’ in cancer therapy (2022) (1)
Immortality improves cell reprogramming (2009) (1)
Coronavirus variant threatens global recovery (2021) (1)
Universities evolve, looking to Darwin for new medical insights. (2010) (1)
The science behind COVID’s assault on smell (2022) (1)
Cancer’s new normal (2021) (1)
Biologists rally to sequence 'neglected' microbes (2009) (1)
Adaptive methods help drug sponsors find best treatment dose (2014) (1)
Uncommon ventures launch to tackle uncommon diseases (2013) (1)
Good vibrations (2011) (1)
Nomination bungle leaves CIRM leadership in limbo. (2011) (1)
This is how an Alzheimer’s gene ravages the brain (2022) (1)
Anticounterfeit campaigners go back to school (2010) (1)
Profiting from Pluripotency (2009) (1)
Newer antidepressants go beyond serotonin—and the synapse (2010) (1)
New stem cell line shows roots of retardation (2007) (1)
IL-2 upgrades show promise at ASCO (2022) (1)
Therapeutic developments: Masters of medicine (2017) (1)
Aura of mystery (2013) (1)
Taking the tripping out of psychedelic medicine (2022) (1)
FDA reversal sends mixed message to multiple sclerosis community (2014) (1)
News Feature: Radiation redux (2017) (1)
Breaking big Ag's fertilizer addiction [Blueprints for a Miracle] (2018) (1)
Therapeutics: Negative feedback (2014) (1)
CAR-Ts move beyond B-cell cancers to myeloma (2017) (1)
Closing in on a cure for hepatitis B (2022) (1)
How going green can raise cash for your lab. (2018) (1)
RNA IS SUPPOSED TO SILENCE GENES, NOT BOOST GENE EXPRESSION SO WHY ARE SCIENTISTS SEEING JUST THAT? (2009) (1)
Mystery disease sleuthing grows—with and without NIH funding (2014) (1)
Scientists brew cannabis using hacked beer yeast (2019) (1)
Trial settles debate over best design for mRNA in COVID vaccines (2023) (1)
Child DNA donors should have their say (2009) (1)
After Avandia, some seek split in drug approval and monitoring (2010) (1)
Stem cells: Transplants on trial (2011) (1)
Britain reevaluates taxes on patent income. (2010) (0)
Drug-free organ transplants without tissue matching (2012) (0)
Chikungunya and Lyme vaccines make headway (2023) (0)
Publisher Correction: Diabetes cell therapies take evasive action (2022) (0)
Precision therapies take aim at non-Hodgkin’s lymphoma (2018) (0)
Could CAR-T-cell therapy offer hope to children with cancer? (2022) (0)
Prepandemic Preparedness under the Spotlight at ASGCT’s COVID-19 Symposium (2020) (0)
Transmission catalog proposed to help combat zoonotic diseases (2014) (0)
Getting on cancer's nerves (2017) (0)
Gene silencing predicted to improve drug manufacturing (2009) (0)
Cancer–neuronal crosstalk and the startups working to silence it (2020) (0)
Flab and freckles could advance stem cell research (2009) (0)
Arthritis Gets a Jolt: 2023 Will See the Results of Nerve Stimulation for Autoimmune Disorders (2023) (0)
Controversial egg-producing stem cells promise better IVF (2012) (0)
Publisher Correction: Treg engineers take aim at autoimmunity (2022) (0)
Alzheimer’s disease is getting easier to spot (2018) (0)
The kill-switch for CRISPR that could make gene-editing safer (2020) (0)
Fighting cancer with microbes (2020) (0)
IGF-1R drugs travel from cancer cradle to Graves’ (2020) (0)
How cells’ ‘lava lamp’ effect could make cancer drugs more powerful (2020) (0)
Healthy chimeras span species (2007) (0)
Lazy male spiders avoid dinner date (2009) (0)
A gene for feathered fellas (2009) (0)
TYK2-blocking agent showcases power of atypical kinase (2022) (0)
Pathologists scan for options beyond autopsies (2010) (0)
Geneticists call for better draft sequences (2009) (0)
The hunt for the lesser-known funding source (2019) (0)
Straight talk with... María Blasco (2011) (0)
New platforms aim to obliterate silos of participatory science (2014) (0)
Manufacturers push the limits of megacombo vaccines for kids (2013) (0)
Nature's 10. (2017) (0)
Genomics uncovers microbe resistance. (2010) (0)
Massive NIH–industry project opens portals to target validation (2019) (0)
Innermost desires (2012) (0)
Straight talk with... Amanda Glassman (2011) (0)
Plasticity of the pluripotent (2008) (0)
Stimulus money unveiled for green cars (2009) (0)
When Huntington’s disease comes early (2018) (0)
‘Bubble boy’ gene therapy reignites commercial interest (2019) (0)
Start-up tries bidding model to outsource academic research (2011) (0)
Advocates to bring rare disease philanthropy under one umbrella (2010) (0)
Half-century-old TB drugs get a facelift in new cocktails (2010) (0)
Genomics: Art of the hypothetical (2013) (0)
Grow your own prostate (2008) (0)
Cancer-eating immune cells kitted out with CARs (2020) (0)
Lp(a)-lowering drugs bolster cardiovascular pipeline (2020) (0)
The world at their feet (2018) (0)
Publisher Correction: ‘Super-antibodies’ could curb COVID-19 and help avert future pandemics (2021) (0)
Treatments aim to topple papillomavirus before cancer begins (2010) (0)
Hope for haploinsufficiency diseases (2023) (0)
Head of stem-cell agency reverses decision to quit (2010) (0)
Selective sequencing solves a genetic mystery (2009) (0)
Protein burns its evolutionary bridges (2009) (0)
How a pioneering diabetes drug offers hope for preventing autoimmune disorders (2023) (0)
BTK blockers make headway in multiple sclerosis (2021) (0)
Audio long-read: How drugmakers can be better prepared for the next pandemic. (2021) (0)
Gene therapy could remedy Parkinson's (2009) (0)
Stem cells made without new genes (2010) (0)
How secret conversations inside cells are transforming biology (2019) (0)
Year of the Compound (2009) (0)
Straight talk with... Mahendra Rao (2011) (0)
The dappled dilemma facing vitiligo science (2019) (0)
Treating sleep apnea with pills instead of machines (2020) (0)
What legal weed in Canada means for science (2018) (0)
NASH therapies head toward landmark approval. (2023) (0)
In utero intervention to stem the damage of cystic fibrosis (2020) (0)
Publisher Correction: Send in the senolytics (2021) (0)
The biological clean-ups that could combat age-related disease (2022) (0)
Scientists downsize bold plan to make human genome from scratch (2018) (0)
Why I'm on a mission to save humanity's ancient microbiome (2019) (0)
Twenty four gene fusions in one drug approval (2018) (0)
HER3-addicted tumors: how biotechs are closing in (2022) (0)
Biomarking the way (2011) (0)
Trial in youngest group points to HIV treatment overhaul (2011) (0)
Sizzling interest in lab-grown meat belies lack of basic research (2019) (0)
Dengue deluge highlights need for vaccine (2013) (0)
The sounds of science: biochemistry and the cosmos inspire new music (2019) (0)
The wide world of weed research (2018) (0)
Precision therapies take aim at non-Hodgkin’s lymphoma (2018) (0)
Biomedical grant awarded by 'American Idol'-style public vote (2012) (0)
The fish that loves to live in trees (2007) (0)
Growing blood in a dish (2008) (0)
‘Warm transplants’ save livers and lives (2018) (0)
Row at US journal widens (2009) (0)
A timeline of new CIRM funding initiatives (2010) (0)
How to ruin cancer’s day (2018) (0)
Nature’s 10: ten people who helped shape science in 2020 (2020) (0)
Behind the paper: saved from the drain (2010) (0)
EraCal Therapeutics: a new drug candidate for obesity (2020) (0)
Biotech news from around the world (2022) (0)
State stem cell agency floats idea of $70 million 'Alpha' clinics (2013) (0)
Biologists turn against worm (2009) (0)
Responding to the call of home (2019) (0)
First CD123-targeted drug approved after wowing in rare cancer (2019) (0)
The mysterious extinction of the dire wolf (2021) (0)
Genomic focus brings tea research to the boil (2019) (0)
Industry's influence in biologics legislation examined (2010) (0)
A Rosa by any other gene (2007) (0)
Behind the paper: muzzling muscle spasticity (2010) (0)
T-cell vaccines could top up immunity to COVID, as variants loom large (2021) (0)
There’s no limit to longevity, says study that revives human lifespan debate (2018) (0)
Fungus genome boosts fight to save North American forests (2009) (0)
In good company. (2017) (0)
NIH goes back to college for peer review (2010) (0)
Fresh targets give hope for HIV vaccine (2009) (0)
Publisher Correction: Radioactive drugs emerge from the shadows to storm the market (2019) (0)
Embryonic stem cells step up to the platelet (2008) (0)
Overstretched medical mystery program takes a breather (2011) (0)
Legalese creates consent 'conundrum' in clinical trials (2010) (0)
Publisher Correction: Treg engineers take aim at autoimmunity (2022) (0)
Elephants, Dolphins, and Chimps need the Internet, too: A new initiative promotes Internet communication among smart animals - [News] (2019) (0)
First Rounders: Robert Langer (2019) (0)
Straight talk with...Donna Ambrosino (2011) (0)
Turning transient structures into drug targets. (2021) (0)
With bated breath, companies await approval for inhalable drugs (2012) (0)
CAR T Cells Detectable More than 10 Years Later. (2022) (0)
Global initiative targets progressive multiple sclerosis (2014) (0)
Ancient origin for monkey version of HIV (2010) (0)
Biodefence lab criticized (2009) (0)
Could tracking RNA in body fluids reveal disease? (2020) (0)
Finding new muscle in cardiac stem cells (2008) (0)
Human-chimp interbreeding challenged (2009) (0)
Out for blood in the search to stall aging (2021) (0)
Vaccine Technologies Jockey for Primacy in Pandemic Response (2021) (0)
Pounds for Paws (2007) (0)
Basic animal research on the rise while pharma looks to new options (2010) (0)
Parkinson’s drug makers target inflammasome (2019) (0)
NIH goes back to college for peer review. (2010) (0)
Cancer drug approvals and setbacks in 2022 (2022) (0)
Anticancer autophagy inhibitors attract ‘resurgent’ interest (2019) (0)
Radioactive drugs emerge from the shadows to storm the market (2018) (0)
Drug for delaying diabetes wins landmark approval (2023) (0)
Flu shot guidelines criticized (2009) (0)
Success with iPSCs (2009) (0)
Publisher Correction: Cancer’s new normal (2022) (0)
Straight talk with...Joel Kupersmith (2011) (0)
The ascent of Moderna (2022) (0)
Publisher Correction: Antibody engineers seek optimal drug targeting TIGIT checkpoint (2020) (0)
University tightens oversight of sensitive research (2009) (0)
Sugar treatment doesn't pacify those concerned about preemies (2010) (0)
Researchers unite to improve Parkinson's drug discovery (2010) (0)
Immunotherapy takes aim at exhausted T cells (2020) (0)
Gawande floats idea for health delivery institute (2010) (0)
Profile: Michael Sporn: A legacy of greater knowledge (2017) (0)
'Remarkable' AI tool designs mRNA vaccines that are more potent and stable. (2023) (0)
How to start a lab when funds are tight (2018) (0)
Migraine drug race turns its final corner, FDA decisions in sight (2018) (0)
The low-down on the Sanofi-Aventis shake-up (2009) (0)
A screen for cancer killers (2009) (0)
The effects of breeding systems on genetic architecture (2008) (0)
Straight talk with ... Rajiv Shah (2010) (0)
Bug sexual warfare drives gender bender (2007) (0)
PredictImmune: a blood test to tailor treatment for bowel condition (2020) (0)
Prospects improve for long-lasting flu vaccine (2010) (0)
Europe reviews primate rights rules (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Elie S. Dolgin?

Elie S. Dolgin is affiliated with the following schools:

University of Edinburgh

Elie S. Dolgin's Academic­Influence.com Rankings